loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 204627 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 PADAGIS US (1)

filter

01 SOLUTION;ORAL (1)

filter

01 RX (1)

filter

01 HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE (1)

filter

01 No (1)

URL Supplier Web Content
SOLUTION; ORAL
4MG/5ML;5MG/5ML;60...
2014-04-29
204627
HYDROCODONE BITART...
RX
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 204627

Looking for FDA Orange Book APPLICATION 204627 1

19

Padagis, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

They are recognized for Setting a smart pace for the extended Topicals Rx marketplace.

One of their notable products is CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE, with a corresponding application number 204627.

Regulatory Information RX

With a dosage strength 4MG/5ML;5MG/5ML;60MG/5ML

Dosage Form Route SOLUTION; ORAL

Reference Listed Drug No

Approved since 2014-04-29

Post Enquiry
POST ENQUIRY